Skip to main content

Closed

OTLK: Outlook Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin-18182.8%

ROIC5446.1%

Financially safe

Stretched

Debt / equity-0.94×

Interest coverage-193.2×

Current ratio0.54×

Outlook Therapeutics, Inc.

OTLKNASDAQ Capital Market·USD·Closed

Outlook Therapeutics, Inc.

OTLKNASDAQ·USD·Closed

$0.98

−6.10%

$0.98

−$0.06 (6.10%)

52W Range

25thpctl

Volume

0.37×avg

Mkt Cap

40.18MUSD

P/E

-0.7TTM

Div Yield

–ann

52W Range

25thpctl

Volume

0.37×avg

Market Cap

40.18MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings